Related Experiment Video

Updated: Aug 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction

Michael Haude1, Rainer Schulz, Gerd Heusch

  • 1University Clinic Essen, Cardiology Clinic, West German Heart Center, Essen, Germany. michael.haude@uni-essen.de

Expert Review of Cardiovascular Therapy
|August 4, 2005
PubMed

Insights

Acute ST-elevation myocardial infarction (STEMI) treatment involves pharmacologic thrombolysis and mechanical reperfusion. This review covers current strategies, guidelines, and future perspectives for STEMI management.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Emergency Medicine

Background:

  • Acute coronary syndrome (ACS) pathogenesis involves atherosclerotic plaque rupture and coronary thrombosis.
  • ST-elevation myocardial infarction (STEMI) is a critical manifestation of ACS.

Purpose of the Study:

  • To review contemporary treatment strategies for acute ST-elevation myocardial infarction.
  • To discuss pharmacologic thrombolysis and mechanical reperfusion in STEMI management.

Main Methods:

  • Review of current treatment guidelines for STEMI.
  • Inclusion of recent information not yet in guidelines.
  • Outline of future treatment perspectives for STEMI.

Main Results:

  • Focus on reperfusion therapies: pharmacologic thrombolysis and percutaneous transluminal coronary angioplasty (PTCA).
  • Integration of latest guideline statements for STEMI treatment.
  • Presentation of emerging data beyond current guidelines.

Conclusions:

  • Contemporary STEMI management emphasizes timely reperfusion.
  • Guidelines and recent data inform optimal treatment pathways.
  • Future research directions aim to further improve STEMI outcomes.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...